Urinary Incontinence After Radical Prostatectomy
1 other identifier
interventional
66
1 country
1
Brief Summary
The aims of this project are; 1) To examine the efficacy of ultrasound-guided pelvic floor muscle training compared to standard care on urinary incontinence in patients undergoing robot assisted radical prostatectomy and 2) To compare physical function, incontinence, and QoL in two groups of patients with low or high function of the pelvic floor muscles respectively before the surgery. This study consists of two parts. The first part is a randomized controlled trial where 44 patients with weak pelvic floor muscle function are randomized to either treatment as usual (control group 1) or ultrasound-guided pelvic floor muscle training (Intervention group). In the second part the patients in control group 1 will be compared with 22 patients with normal/strong pelvic floor muscle function (control group 2). Patients not able to perform the pelvic floor muscle test consisting of 8 repetitions of 4-seconds pelvic floor muscle contraction and 1 repetition of 15-seconds pelvic floor muscle contraction will be randomized to either intervention group or control group 1. Patients able to perform the pelvic floor muscle test will be included in control group 2.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 12, 2022
CompletedFirst Submitted
Initial submission to the registry
October 27, 2022
CompletedFirst Posted
Study publicly available on registry
November 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedNovember 22, 2022
November 1, 2022
2 years
October 27, 2022
November 14, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
24-hour pad weigh test
The patients have to weigh their pads before use and retain them in sealed plastic bags for repeated weight assessment when the 24-hour period has ended. The total increase in weight (gram) of all the pads will be recorded
12 month after the operation
Study Arms (3)
Intervention group
EXPERIMENTALThe intervention group receives same treatment as the control groups and in addition transperinal ultrasound guided instruction in pelvic floor muscle training at 2nd and 3rd session.
Control group 1
NO INTERVENTIONThe patients recieve standard care including three physiotherapist sessions; within one week preoperatively, one week postoperatively at catheter removal, and six weeks postoperatively
Control group 2
NO INTERVENTIONThe patients recieve standard care including three physiotherapist sessions; within one week preoperatively, one week postoperatively at catheter removal, and six weeks postoperatively
Interventions
The physiotherapists uses transperinal ultrasound as a biofeedback or pedagogical tool to improve the muscle contractions and visualize the muscle work.
Eligibility Criteria
You may qualify if:
- Men aged 18 and above
- Diagnosis of prostatic adenocarcinoma and referred to robot assisted radical prostatectomy
- No comorbidity that prevents pelvic floor training or effects the function of the pelvic floor
- Adequacy in written and spoken Danish Performance status 0-1
- Able to understand the study procedures and willing to provide written informed consent
You may not qualify if:
- Major surgery within the last month that may affect pelvic floor function.
- Urinary incontinence prior to surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Regional Hospital Goedstrup
Herning, 7400, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
October 27, 2022
First Posted
November 22, 2022
Study Start
October 12, 2022
Primary Completion
October 1, 2024
Study Completion
October 1, 2025
Last Updated
November 22, 2022
Record last verified: 2022-11